Metrics as of 10/15/2026, 01:39 PM (Berlin time), refresh in progress.
biote Stock
biote Corp.
Company data
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Country
- United States
- CEO
- Robert C. Peterson
- Employees
- 223
- Market cap
- $50 M
- IPO
- 28/04/2021
- Web
- biote.com
Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the…
biote stock: price history
1D
+8.7%
1W
+1.8%
1M
-19.3%
6M
-42.6%
YTD
-56.5%
1Y
-60.1%
2Y
-78.3%
5Y
-88.4%
10Y
–
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~87% stronger price swings than usual
Ask the agents about biote
Analyst assessment of biote
PRICE TARGET LOW
US$4.00
CONSENSUS
US$4.00
MEDIAN
US$4.00
PRICE TARGET HIGH
US$4.00
0
STRONG BUY
6
BUY
1
HOLD
0
SELL
0
STRONG SELL
7
TOTAL · Buy
As of: 10/08/2026
biote stock metrics
P/E
6.73
P/B
-0.49
EV/EBITDA
7.13
RETURN ON EQUITY
10.0%
NET MARGIN
-14.8%
DEBT/EQUITY
-1.96
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
91.0%
FLOAT SHARES
40,144,739
AVG. DAILY VOLUME (30D)
155,048
Insider transactions (SEC)
Beer Marc D
Beer Marc D
MORRIS DEBRA L
Institutional holders
Comparable stocks
Frequently asked questions about biote stock
What does biote do?
biote Corp. is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in United States.
The CEO is Robert C. Peterson, the company employs around 223 people.
The IPO was on 28/04/2021; the stock trades on NASDAQ under the ticker BTMD.
What do analysts say about biote stock?
7 analysts rate the stock, the consensus is Buy (as of 10/08/2026).
The average price target is US$4.00, ranging from US$4.00 to US$4.00, with a median of US$4.00.
This is an external assessment, not a statement by Market Jury.
When does biote report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 87% stronger than usual.
Does biote pay a dividend?
No, biote currently does not pay a dividend.
Which stocks are comparable to biote?
Comparable stocks include HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health, LifeStance Health Group, Concentra Group Holdings Parent and Acadia Healthcare Company.
How can I get biote stock analyzed?
Clicking "Analyze stock" lets five strategies assess biote against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.